JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,414,000 | $5,508,000 | $5,412,000 | $19,404,000 |
| Dep. & Amort. | $3,374,000 | $3,197,000 | $1,997,000 | $1,945,000 |
| Deferred Tax | $0 | $0 | -$9,221,000 | -$3,074,000 |
| Stock-Based Comp. | $9,000 | $71,000 | $173,000 | $177,000 |
| Change in WC | -$74,000 | -$6,055,000 | -$2,956,000 | -$9,030,000 |
| Other Non-Cash | -$2,381,000 | $6,591,000 | -$905,000 | -$133,000 |
| Operating Cash Flow | -$5,486,000 | $9,312,000 | -$5,500,000 | $9,289,000 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,888,000 | -$2,095,000 | -$8,560,000 | -$11,333,000 |
| Net Acquisitions | $145,000 | -$600,000 | -$6,717,000 | $8,167,000 |
| Inv. Purchases | $0 | $0 | -$906,000 | -$300,000 |
| Inv. Sales/Matur. | $0 | $0 | $259,000 | $300,000 |
| Other Inv. Act. | -$131,000 | $5,000 | $922,000 | -$84,000 |
| Investing Cash Flow | -$9,874,000 | -$2,690,000 | -$15,002,000 | -$3,250,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $14,805,000 | $500,000 | $4,700,000 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2,530,000 | $15,000 | $10,000 | $10,000 |
| Dividends Paid | -$2,505,000 | -$2,500,000 | -$2,739,000 | -$2,169,000 |
| Other Fin. Act. | -$55,000 | -$46,000 | -$23,000 | -$20,000 |
| Financing Cash Flow | $9,736,000 | -$2,031,000 | $1,948,000 | -$2,179,000 |
| Forex Effect | $64,000 | $886,000 | $1,099,000 | $612,000 |
| Net Chg. in Cash | -$5,560,000 | $5,478,000 | -$17,455,000 | $4,473,000 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,756,000 | $13,278,000 | $30,733,000 | $26,260,000 |
| End Cash | $13,196,000 | $18,756,000 | $13,278,000 | $30,733,000 |
| Free Cash Flow | -$15,374,000 | $7,217,000 | -$14,060,000 | -$2,044,000 |